Skip to content
RDL Network logo
Evaluation of Treatment Outcomes Using <scp>dNLR</scp> and <scp>GNRI</scp> in Combination Therapy With Atezolizumab and Bevacizumab for Hepatocellular Carcinoma — Atsushi Naganuma (2025) | RDL Network